Showing results out of
The Kowalinski group at EMBL Grenoble identified significant differences between the trypanosomal and human nuclear cap-binding complex, a key player in cellular RNA metabolism and a potential target for novel anti-parasitic drugs.
SCIENCE & TECHNOLOGY2025
science-technology
Scientists have discovered how the antiviral protein TRIM25 finds and binds viral RNA to activate an innate immune response.
SCIENCE & TECHNOLOGY2024
science-technology
EMBL and partners announce ‘Amplifying Funds in Infection Biology’ to foster interdisciplinary and collaborative research in infection biology.
EMBL ANNOUNCEMENTS2024
embl-announcements
Jan Kosinski, Group Leader at EMBL Hamburg and one of the co-chairs of the Infection Biology theme in EMBL’s new programme, chats about how this theme will support his work and help establish new collaborations.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
John Lees joins EMBL-EBI as a Group Leader in Pathogen informatics and modelling.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Zamin Iqbal and his team are working with researchers all over the globe to help put a stop to Tuberculosis
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
EMBL hosted a futuristic infection biology conference, but it offered even more: an opportunity for postdocs to share their work and network towards future research homes.
LAB MATTERS2022
eventslab-matters
No results found